Cargando…

Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy

BACKGROUND: Risk of pneumocystosis after discontinuation of primary or secondary prophylaxis among HIV-infected patients before CD4 counts increase to ≧200 cells/μL (early discontinuation) after receiving highly active antiretroviral therapy (HAART) is rarely investigated. METHODS: Medical records o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Chien-Yu, Chen, Mao-Yuan, Hsieh, Szu-Min, Sheng, Wang-Huei, Sun, Hsin-Yun, Lo, Yi-Chun, Liu, Wen-Chun, Hung, Chien-Ching
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885390/ https://www.ncbi.nlm.nih.gov/pubmed/20492660 http://dx.doi.org/10.1186/1471-2334-10-126

Ejemplares similares

The lung microbiome in patients with pneumocystosis
por: Kehrmann, J., et al.
Publicado: (2017)

Pneumocystosis in a lurcher puppy
por: Giannoulopoulos, George, et al.
Publicado: (2020)

Gaining an Understanding of Pneumocystosis in Wales
por: Ayling-Smith, Jonathan, et al.
Publicado: (2023)

Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors
por: Chiang, Hou-Hsien, et al.
Publicado: (2011)

Contribution of the qPCR for the Diagnosis of Pneumocystosis
por: Issa, Nahema, et al.
Publicado: (2017)

Oculosystemic pneumocystosis in 2 sibling Chihuahuas
por: Johnson, Lynelle R., et al.
Publicado: (2023)

Immune Reconstitution Inflammatory Syndrome in People Living with HIV Who Presented with Interstitial Pneumonitis: an Emerging Challenge in the Era of Rapid Initiation of Antiretroviral Therapy
por: Chen, Kai-Hsiang, et al.
Publicado: (2023)

Non-traumatic perforation of the jejunum in a human immunodeficiency virus-infected patient receiving combination antiretroviral therapy: A case report
por: Lee, Yi-Chien, et al.
Publicado: (2019)

Therapeutic Drug Monitoring and Pharmacogenetic Study of HIV-Infected Ethnic Chinese Receiving Efavirenz-Containing Antiretroviral Therapy with or without Rifampicin-Based Anti-Tuberculous Therapy
por: Lee, Kuan-Yeh, et al.
Publicado: (2014)

Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan
por: Wu, Pei-Ying, et al.
Publicado: (2017)

Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
por: Chen, Guan-Jhou, et al.
Publicado: (2019)

Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy
por: Tsai, Mao-Song, et al.
Publicado: (2014)

Performance of fracture risk assessment tool in HIV‐positive male individuals aged ≥45 years on suppressive antiretroviral therapy
por: Tsai, Mao‐Song, et al.
Publicado: (2019)

Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure
por: Hsieh, Szu-Min, et al.
Publicado: (2009)

Comorbidities among the HIV-Infected Patients Aged 40 Years or Older in Taiwan
por: Wu, Pei-Ying, et al.
Publicado: (2014)

Genetic polymorphisms associated with treatment failure and mortality in pediatric Pneumocystosis
por: Singh, Yogita, et al.
Publicado: (2019)

Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation
por: Fonte, Luis, et al.
Publicado: (2021)

Long-term immune responses and comparative effectiveness of one or two doses of 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of combination antiretroviral therapy
por: Cheng, Aristine, et al.
Publicado: (2016)

National Trend and Characteristics of Acute Hepatitis C among HIV-Infected Individuals: A Matched Case-Control Study—Taiwan, 2001–2014
por: Lo, Yi-Chun, et al.
Publicado: (2015)

Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy
por: Ho, Ming-Yun, et al.
Publicado: (2021)

Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
por: Liu, Chen-Hua, et al.
Publicado: (2015)

Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey
por: Lee, Yi-Chieh, et al.
Publicado: (2017)

Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak()
por: Lin, Kuan-Yin, et al.
Publicado: (2022)

Hepatitis C microelimination among people living with HIV in Taiwan
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

Epidemiological characteristics of pulmonary pneumocystosis and concurrent infections in pigs in Jeju Island, Korea
por: Kim, Ki-Seung, et al.
Publicado: (2011)

COVID-19–related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis
por: Blaize, Marion, et al.
Publicado: (2020)

Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan
por: Chang, Sui-Yuan, et al.
Publicado: (2016)

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial
por: Polyak, Christina S., et al.
Publicado: (2016)

Lumbar puncture for non-HIV-infected non-transplant patients with cryptococcosis: Should it be mandatory for all?
por: Huang, Sung-Hsi, et al.
Publicado: (2019)

Serological diagnosis of pneumocystosis: production of a synthetic recombinant antigen for immunodetection of Pneumocystis jirovecii
por: Tomás, A. L., et al.
Publicado: (2016)

Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
por: Huang, Sung-Hsi, et al.
Publicado: (2017)

Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy
por: Taylor, Allan W., et al.
Publicado: (2013)

Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy
por: Lin, Kuan-Yin, et al.
Publicado: (2015)

Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART
por: Franconi, Iacopo, et al.
Publicado: (2019)

Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up
por: Lin, Kuan-Yin, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis
por: Rayens, Emily, et al.
Publicado: (2022)

High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan
por: Tang, Jih-Luh, et al.
Publicado: (2015)

Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan
por: Huang, Miao-Hui, et al.
Publicado: (2021)

Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
por: Liu, Wang-Da, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d456qjq8sfs01m792t1vc8glnt